Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Stimulant Medication on Disruptive Behavior in ADHD
NCT03420339Phase 4Recruiting
- Start
- Oct 2018
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in attention deficit hyperactivity disorder (ADHD). Primary endpoints: Change in Behavioral Function at 4 weeks, Change in Item Preference at 8 weeks and 2 more. Started Oct 2018; status: recruiting.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03420339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420339.